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Abstract
The purpose of this study was to confirm previously reported associations of common variants in or near CDC7/TGFBR3, ZP4,
SRBD1, ELOVL5, CAV1/CAV2, TLR4, CDKN2B, CDKN2B-AS1, ATOH7, PLXDC2, TMTC2, SIX1, and CARD10, with primary open angle
glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. A total of 437 unrelated subjects from the
Barbados Family Study of Open Angle Glaucoma (BFSG), including 272 with POAG and 165 unaffected individuals were
included in this study. Eighteen SNPs were genotyped by using the multiplex SNaPshot method. Allelic, genotypic and
model-based (dominant, recessive, and additive) associations of the SNPs with POAG were analyzed using Chi-squared tests
and logistic regression. SNP rs1063192 (near CDKN2B) was found to be significantly associated with POAG (allelic P=0.0008,
genotypic P=0.0029), and the minor allele C of rs1063192 was protective against POAG (OR =0.39; 95%CI =0.2220.69).
Suggestive association was also noted for rs7916697 (near ATHO7, allelic P =0.0096, genotypic P=0.01) with the minor
allele being protective (OR =0.67; 95% CI =0.5020.91), although this finding did not withstand correction for multiple
testing. However, a significant interactive effect on POAG risk was identified between rs1063192 and rs7916697 (P-
interaction =2.80610
25). Individuals with the rs1063192 protective genotype CC or CT and also rs7916697 genotypes GG or
GA show a significantly decreased risk of POAG (OR=0.17, 95%CI: 0.0720.41). Our study confirms the significant association
between SNP rs1063192 (CDKN2B, previously shown to influence vertical cup-to-disc ratio and POAG at 9p21) and POAG in
the Afro-Caribbean population of Barbados. The minor allele of rs1063192 interacts with that of rs7916697 (ATOH7)) to
reduce POAG risk. Our results also suggest that rs1063912 is a common protective variant for POAG in populations of
African as well as European descent.
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Introduction
Glaucoma is a complex disease characterized by degeneration
of the optic nerve, often associated with increased intraocular
pressure. It has been estimated that over 11.1 million people will
be bilaterally blind from primary glaucoma by 2020 [1], making it
the second leading cause of blindness worldwide. Primary open
angle glaucoma (POAG) is more prevalent than primary angle
closure glaucoma (PACG) in most populations. The prevalence of
POAG increases markedly with age, and POAG tends to be more
frequent in African derived populations [2], and especially in Afro-
Caribbean populations [3,4]. Progression of POAG is often
painless and significant loss of vision can occur before patients seek
ophthalmological care, so that identifying new ways to diagnose
POAG early in its course or even predict its risk before visual loss
occurs is of critical importance.
There is increasing evidence that POAG, and especially its
endophenotypes, have a genetic component [5,6,7,8]._ENREF_8
Familial aggregation of POAG has been documented in the
general population [9,10], and a high concordance of POAG
between monozygotic twins has been observed, suggesting that
genetic factors may play important roles in the pathogenesis of this
disease [11,12]. Linkage analyses have established three POAG
susceptibility genes: myocilin (MYOC) [13], optineurin (OPTN) [14],
and WD repeat domain 36 (WDR36) [15]. However, taken together
these genes only account for 3%-5% of sporadic POAG cases [8].
Therefore, candidate gene approaches and genome-wide associ-
ation studies (GWAS) have been applied increasingly to investigate
the molecular basis of this polygenic disease.
Recently a Japanese study using candidate gene methods found
multiple SNPs in the toll-like receptor 4 (TLR4) gene associated with
the risk of normal tension glaucoma (NTG) [16], with an allelic P
value of 0.0041 in the most highly associated SNP, rs7037117. In
addition, six SNPs (rs547984, rs540782, rs693421, rs2499601,
rs7081455 and rs7961953) comprising 3 different loci were
modestly associated with POAG in a GWAS carried out on
1,575 Japanese subjects [17]. Another Japanese group carried out
a separate GWAS, identifying S1 RNA binding domain 1 (SRBD1)
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for both normal tension glaucoma (NTG) and POAG (with the
most highly associated SNPs being rs3213787 in SRBD1 and
rs735860 in ELOVL5) [18]. In addition, a GWAS performed in an
Icelandic population for POAG identified significant associations
with SNPs between the caveolin 1 (CAV1) and caveolin 2 (CAV2) genes
on chromosome 7q31, with the tightest association being to
rs4236601 [19].
In part because the complex genetics of POAG have tended to
resist direct analysis, attention has turned to a group of
endophenotypes that are thought to contribute to or mark POAG,
including cup-to-disc ratio and optic disc area [20]. Three groups
have recently carried out GWAS using quantitative analytical
approaches and identified several genomic regions showing
associations with optic disc area and vertical cup-to-disc ratio
(VCDR). Studies in Rotterdam and Singapore have identified
significant association between optic disc area and alleles of SNPs
near cell division cycle 7 homolog (CDC7), transforming growth factor, beta
receptor III (TGFBR3, rs1192415), caspase recruitment domain family,
member 10 (CARD10, rs9607469), and atonal homolog 7 (ATOH7,
rs1900004 and rs7916697) [21,22,23]. In addition, a GWAS in
two Australian twin cohorts identified an association between
rs3858145 near the ATOH7 gene and mean disc area [21]. The
Rotterdam and Singapore study also identified two loci associated
with VCDR in a GWAS, rs1063192 in the cyclin-dependent kinase
inhibitor 2B (CDKN2B) gene on chromosome 9p21, and rs10483727
on chromosome 14q22.3-q23 near the SIX homeobox 1 (SIX1) gene
[24]. Some of the above genomic regions related to optic disc area
or VCDR have been tested for association with POAG in
Caucasians, yielding two SNPs significantly associated with POAG
(rs1063192 and rs10483727 in the CDKN2B and SIX regions,
respectively) [8,24]. A later GWAS in Australians of European
descent with advanced POAG found association with rs4977756,
which is near the CDKN2B antisense RNA 1 (CDKN2B-AS1, ANRIL)
and in tight linkage disequilibrium with rs1063192. CDKN2B-AS1
is adjacent to and regulates expression of the CDKN2B and
CDKN2A genes [25].
However, all the GWAS described above were carried out in
Caucasian or Asian populations, as were the subsequent confir-
mation studies. Replication, especially in other ethnic groups, is
essential for establishing the credibility of a genotype –phenotype
association and to avoid peculiarities of single populations. One
such alternative population group consists of individuals of African
ethnic origin, in which POAG tends to be more predominant and
progresses more rapidly than in most other ethnic groups
[3,26,27]. This study evaluated the association between POAG
and these SNPs in the Afro-Caribbean population of Barbados,
confirming association to rs1063192 near CDKN2B and demon-
strating an interactive effect between rs1063192 and rs7916697 in
the ATOH7 region on POAG risk.
Materials and Methods
Study Population
This study was approved by the Institutional Review Boards of
Stony Brook University Medical Center, the Barbados Ministry of
Health and the National Institutes of Health Combined Neuro-
science Institutional Review Boards. All participants provided
written informed consent before participation in the study, and the
study protocols conformed to the Declaration of Helsinki.
This investigation included 272 unrelated POAG patients and
165 unrelated controls from the Barbados Family Study of
Glaucoma (BFSG) [9,28], a follow-up study to the Barbados Eye
Study [3] initiated in 1988. Controls were unaffected spouses
recruited through the BFSG and unaffected individuals ascer-
tained through the glaucoma clinic of the Queen Elizabeth
Hospital, all of whom were unrelated. Briefly, first degree relatives
of a POAG proband in the BES were invited to participate in the
family study, and recruitment was further extended to first degree
relatives of family members found to have POAG. Recruitment
and diagnostic criteria for the BFSG were describe in detail by
Nemesure et al. [29] and selection for the association study was
detailed in Jiao et al. [28] and in Table 1.
All participants received a comprehensive examination in-
cluding anthropometric and blood pressure measurements, best
corrected visual acuity based on the ETDRS chart, Humphrey
perimetry with the C64 suprathreshold program, C24-2 and C30-
2 full threshold programs, applanation tonometry, pupil dilation,
lens grading with the lens opacities classification system II [30] by
slit lamp, and color stereo fundus photographs of the disc and
macula. All participants also received a comprehensive examina-
tion by the study’s ophthalmologists and an interview including
medical, ocular, and family history information. A blood sample of
14 ml was obtained from each subject for DNA isolation and EBV
transformation in some cases. Diagnosis of POAG required the
presence of specific signs of glaucomatous optic nerve damage plus
visual field defects, as well as an ophthalmologic evaluation
(Table 1) [31]. Elevated IOP was not a criterion for POAG under
this definition. Control individuals showed none of the signs of
glaucoma listed in Table 1.
Genotyping
Genomic DNA was prepared from peripheral blood lympho-
cytes and from transformed lymphocytes as described elsewhere
[29]. All SNPs were genotyped by using the multiplex SNaPshot
method (Applied Biosystems, Foster City, CA) as described
previously [28]. Genotypes were determined using Genemap-
per4.0 software (Applied Biosystems, Foster City, CA).
Statistical Analysis
Genetic association analyses were performed using the Golden
Helix SNP and Variation Suite 7 (Golden Helix, Bozeman, MT,
USA). All SNPs were analyzed for deviation from Hardy-Weinberg
equilibrium (HWE) using the Chi-squared test. Allelic, genotypic
and model-based (dominant, recessive and additive) associations of
theSNPswithPOAGwereanalyzedusingtheChi-squaredtest.The
odds ratio (OR) and 95% confidence interval (CI) were estimated
using a 2 by 2 table. Gene-gene interactions were analyzed by
including an interaction term in the logistic regression model based
on a dominant model. Correction for multiple comparisons was
carried out using a Bonferroni correction. For quantitative analysis
of IOP the right eye was chosen arbitrarily as values from both eyes
were quite similar (mean IOPod = 22.866.9, IOPos = 23.068.2,
R
2=0.66, p=3.7610
230). Only available IOP values in the
absence of treatment were considered in this analysis (N=113). In
order to achieve normal distribution of the residuals, a log-linear
transformation, log(iop+3), was used before analysis. While this
transformation yielded residuals that could not be distinguished
from a normal distribution with a=0.1, transformations ranging
fromlog(iop-3)tolog(iop+7)yieldeddistributionsmeetingnormality
with a=0.05.
Results
A total of 437 unrelated subjects were recruited in the current
study, including 272 POAG cases and 165 controls. The eighteen
SNPs were genotyped in all subjects. The average ages of POAG
cases is 67.6 and that of controls is 62 years old, and 55% of the
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However, the average ages for affected males and females (67.2
and 68.1, respectively), and unaffected males and females (62 and
62, respectively) are similar, as are the average IOP values for
affected males and females (22.9 and 22.9, respectively) and
unaffected males and females (15.7 and 16.2, respectively). All
SNPs conformed to Hardy-Weinberg equilibrium (HWE) in both
the case and control groups, except for rs7037117 and rs7961953,
which showed minor deviations (combined HWE P=0.005 and
0.001, respectively).
In the basic allelic tests, rs1063192, a SNP that previously was
shown to be associated with VCDR and POAG [8,22,24], was
significantly associated with POAG in Barbadians (allelic
P=0.0008, Table 3) with a genotypic P=0.0029. The C allele
of SNP rs1063192 was more frequent in controls than in patients
with POAG (9.4% vs. 3.9%; OR=0.39, 95%CI: 0.2220.69),
indicating a protective effect of this minor allele. A second SNP,
rs7916697, which has been shown to be related with optic disc
area [23], also showed suggestive association with POAG in this
population (allelic P=0.0096, Table 3) with a corresponding
genotypic P=0.0131. However, after adjusting for multiple testing
using a Bonferroni correction (corrected significant p=0.0021:
0.05/24 for 18 allelic tests for individual SNPs shown in Table 3
and 3 model specific tests for each of 2 SNPs that showed
significant or suggestive allelic p values and are shown in Table 4),
only rs1063192 remained significant.
Association results for rs1063192 and rs7916697 are similar
when examined under dominant and additive models, although no
significant association is seen for any marker under a recessive
model (Table 4). rs1063192 Shows significant association with
POAG in both dominant and additive models with P=0.0010 and
0.0007 for dominant and additive models, respectively; the
dominant OR =0.38 (0.2120.68), Table 4. Again, rs7916697 is
suggestively associated with POAG in both dominant and additive
models (P=0.0034 and 0.0106 for dominant and additive model
respectively; Table 4), but this finding does not remain significant
after a Bonferroni correction for multiple testing (adjusted
corrected significance level =0.0028 for 18 tests). When alleles
at these two markers were tested for association with IOP values,
neither was significant (regression P=0.39 and 0.99 for rs1063192
and rs7916697, respectively) and neither was significantly associ-
ated when IOP was analyzed as a dichotomous trait (allelic X
2
p=0.54 and 0.27, respectively). In contrast, IOP was highly
associated with POAG diagnosis (P=1.5610
210 and 4.4610
28,
for logistic and linear regression, respectively), although elevated
IOP was not a diagnostic criterion for POAG in the BFSG
(Table 1).
Of the two SNPs showing significant or suggestive association
with POAG, rs1063192 is located near the overlapping CDKN2B
and CDKN2B-AS genes and rs7916697 is located near ATOH7
gene. We examined other SNPs in these regions for association
with each other and with POAG. Alleles of the three chromosome
10 SNPs near ATOH7 (rs190004, rs3858145 and rs7916697) did
not show significant association with each other, nor did alleles of
the two SNPs near CDKN2B on chromosome 9 (rs1063192 and
rs4977756). Consistent with the lack of linkage disequilibrium
between alleles of the SNPs themselves, haplotypes of SNPs in
Table 1. Diagnostic criteria for POAG.
Diagnostic test Criteria
Visual field
++ At least two abnormal visual field tests by Humphrey automated perimetry, as defined by computer-based objective criteria, i.e.,
positive results of hemimeridional analyses of threshold tests (C24-2 or C30-2 full-threshold program) and/or the presence of one or
more absolute defects in the central 30 degrees (as tested with the C64 suprathreshold program; 3-zone strategy), with
ophthalmologic interpretation as definite or suspect glaucomatous field loss
+ Less than two abnormal visual field tests or an inability to perform reliable automated perimetry (because of severe visual impairment
or infirmity), with ophthalmologic interpretation as definite glaucomatous field loss
Optic disc
++ At least two signs of optic disc damage present in fundus photographs and/or the ophthalmologic evaluation, including either
a horizontal or vertical cup-disc ratio $0.7, narrowest remaining neuroretinal rim #0.1 disc diameters, notching, asymmetry in cup–
disc ratios between eyes .0.2, or disc hemorrhages
+ Less than two signs of optic disc damage as described above (or unavailable photographs), with an ophthalmologic assessment or
clinical record documenting definite glaucomatous optic nerve damage
Ophthalmologic examination
++ Clinical diagnosis of definite POAG after examination by the study ophthalmologist to exclude other possible causes for disc and field
changes
+ Previous POAG history and treatment and/or visual field and disc damage, although a definite POAG diagnosis was not made at the
time of the BFSG visit (e.g., because of inconclusive or incomplete data); the study ophthalmologist confirmed the diagnosis through
record review or rE-examination
++, most complete classification data; +, less complete but sufficient for classification.
Those with POAG had a minimum of at least one plus (+) sign in each of the three categories.
doi:10.1371/journal.pone.0039278.t001
Table 2. Clinical and demographic characteristics of case and
control individuals.
POAG controls
age (S.D.) 67.6 (11.8) 62.1 (12.4)
males 44.90% 68.60%
IOPod (S.D.) * 22.5 (7.0) 16.3 (3.5)
IOPos (S.D.)* 22.8 (8.3) 16.2 (3.8)
*mm Hg, includes patients receiving therapy.
doi:10.1371/journal.pone.0039278.t002
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dbSNP ID Chromosome Nearest Gene
Minor
Allele
MAF*(%)
POAG
MAF*(%)
Control Chi-Squared P{ Odds Ratio (95% CI) HWE{ P
rs1192415 1 CDC7/TGFBR3 G 19.0 17.1 0.4802 1.14 (0.79–1.64) 0.957
rs547984 1 ZP4 T 31.7 30.5 0.7374 1.05 (0.77–1.44) 0.476
rs540782 1 ZP4 G 31.4 29.9 0.6570 1.07 (0.79–1.46) 0.548
rs693421 1 ZP4 A 31.3 29.1 0.5193 1.11 (0.81–1.52) 0.733
rs2499601 1 ZP4 G 27.1 29.5 0.4440 0.89 (0.66–1.20) 0.528
rs3213787 2 SRBD1 G 0.6 1.2 0.2882 0.45 (0.10–2.03) 0.865
rs735860 2 ELOVL5 T 4.6 6.2 0.3176 0.73 (0.39–1.36) 0.911
rs4236601 7 CAV1/CAV2 A 39.7 36.4 0.3332 1.15 (0.87–1.53) 0.258
rs7037117 9 TLR4 A 22.4 28.2 0.0571 0.73 (0.53–1.01) 0.005 ˆ
rs1063192 9 CDKN2B C 3.9 9.4 0.0008 0.39 (0.22–0.69) 0.640
rs4977756 9 CDKN2B-AS1 G 33.3 35.8 0.4507 0.89 (0.67–1.20) 0.328
rs7916697 10 ATOH7 G 24.4 32.4 0.0096 0.67 (0.50–0.91) 0.589
rs1900004 10 ATOH7 G 31.7 31.3 0.9076 1.02 (0.76–1.37) 0.269
rs3858145 10 ATOH7 G 41.1 41.5 0.9138 0.98 (0.74–1.31) 0.490
rs7081455 10 PLXDC2 G 30.4 29.6 0.8052 1.04 (0.77–1.41) 0.395
rs7961953 12 TMTC2 A 14.2 15.7 0.5559 0.89 (0.61–1.31) 0.001 ˆ
rs10483727 14 SIX1 C 5.6 7.1 0.4151 0.77 (0.42–1.43) 0.604
rs9607469 22 CARD10 A 17.8 16.0 0.5096 1.13 (0.78–1.64) 0.611
*Minor allele frequencies.
{Chi-Squared P-value. The Bonferroni corrected significance level was 0.0021 (=0.05/24, for 18 allelic tests for individual SNPs and 3 model specific tests for eacho f
2 SNPs).
{Hardy–Weinberg equilibrium.
‘For markers out of HWE association was also tested using the Cochran-Armitage trend test with no association being shown (P=0.0573 for rs7037117 and P=0.5561
for rs7961953).
doi:10.1371/journal.pone.0039278.t003
Table 4. Association results of rs1063192 and rs7916697 in different models.
SNPs rs1063192 (CDKN2B) rs7916697 (ATOH7)
Phenotype POAG (n=272) Controls (n=165) POAG (n=271 ˆ) Controls (n=165)
Allelic Analysis
Alleles (%) T* 523 (96.1%) 299 (90.6%) A* 410 (76%) 223 (68%)
C 21 (3.9%) 31 (9.4%) G 132 (24%) 107 (32%)
HWE P 0.51 0.68 0.20 0.40
P
1 OR
2 (95% CI) P
1 OR
2 (95% CI)
Allelic P Values 0.0008 0.39 (0.2220.69) 0.0096 0.67 (0.5020.91)
Genotypic and Model Based Analysis
Genotypes (%) TT 251 (92%) 135 (82%) AA 159 (59%) 73 (44%)
TC 21 (8%) 29 (18%) AG 92 (34%) 77 (47%)
CC 0 (0%) 1 (1%) GG 20 (7%) 15 (9%)
P OR (95% CI) P OR (95% CI)
Additive (Trend) 0.0007 0.0106
Dominant 0.00096 0.38 (0.2120.68) 0.0034 0.56 (0.3820.83)
Recessive 0.6771 n/a
3 0.9901 0.80 (0.4021.60)
‘One sample did not amplify when this marker was tested.
*risk allele, odds ratios are calculated for the minor (protective) allele and genotypes.
1Chi-Squared P-value. The Bonferroni corrected significance level was 0.0021 (=0.05/24, for 18 allelic tests for individual SNPs and 3 model specific tests for eacho f
2 SNPs).
2Odds ratio.
3no individuals were homozygous for the risk allele.
doi:10.1371/journal.pone.0039278.t004
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We then used logistic regression to investigate the joint two-
locus effect of the two SNPs showing significant or suggestive
association with POAG, rs1063192 and rs7916697. The results
indicate a significant interaction effect between these two SNPs as
risk factors for POAG, with comparison of the homozygous major
alleles vs. a dominant model for the minor alleles of rs1063192 and
rs7916697 giving a P interaction=2.80E-5. Individuals with
rs1063192 protective genotype CC or CT and also rs7916697
genotypes GG or GA have a significantly decreased risk of POAG
(OR=0.17, 95%CI: 0.0720.41; Figure 1). In addition, compar-
ison of the full interaction dominant model to rs7916697 alone
yields a P=0.00032, and comparison to rs1063192 alone results in
a P=0.0091, supporting the interactive effect of these two loci
over that of each locus independently. This is consistent with the
odds ratios obtained with a dominant model for each locus in the
regression analysis against the homozygous main alleles for both
markers (OR =0.56, 95% CI: 0.2321.35 for rs1063192 and 0.62,
95% CI: 0.4120.95 for rs7916697) and that for the combination
of both rs1063192 and 7916697 together (OR =0.17, 95%CI:
0.0720.41, Figure 1).
Discussion
POAG is a complex disorder resulting from the combined
interactions of multiple genes and environmental factors, so
dissecting its genetic architecture can be simplified through the
investigation of quantitative traits underlying disease risk. In-
traocular pressure (IOP), optic disc parameters such as VCDR and
optic disc area were reported to correlate genetically with POAG;
therefore, searching for genes influencing these traits can aid in
finding POAG genes even when association with POAG in the
original studies is minimal [32]. In this study we included five
SNPs associated with optic disc area (rs1192415 near CDC7/
TGFBR3; rs9607469 near CARD10; rs190004, rs7916697 and
rs3858145 near ATOH7 ) and three SNPs related with VCDR
(rs1063192 in CDKN2B; rs10483727 near SIX1; and rs4977756
near CDKN2B-AS1) to establish their roles in the pathogenesis of
POAG in a population of African descent. Among the SNPs tested
rs1063192, originally identified as a VCDR quantitative trait locus
on 9q21 located in the 39UTR for CDKN2B and within in an
intron of CDKN2B-AS1 [22], was found to be significantly
associated with POAG in the Afro-Caribbean population of
Barbados. A second SNP, rs7916697 near ATOH7 on chromo-
some 10 and previously related with optic disc area [21,22],
showed a nominal association with POAG although this did not
withstand correction for multiple testing. In addition, risk alleles at
these two SNPs were shown to interact, resulting in an increase in
the risk for POAG with more than an additive effect, and the
combination of both protective genotypes conferred a significantly
decreased risk of POAG compared to that seen with either single
SNP.
Figure 1. Interaction between rs1063192 and rs7916697. Logistic regression modeling showed that the joint effects between rs1063192 and
rs7916697 were interactive (P-interaction=2.80E25).The joint odds ratios were estimated for combinations of protective genotypes of rs1063192 (in
the dominant model) or rs7916697 (in the dominant model) compared with the combination of both risk genotypes (homozygous major alleles for
both markers).
doi:10.1371/journal.pone.0039278.g001
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surprising in this investigation, since the definition of POAG in the
Barbados Family Study of Glaucoma includes changes in the
vertical cup to disc ratio and other disc abnormalities consistent
with POAG as integral parts of the diagnostic criteria. Association
of alleles at these two markers is also consistent with previous
association studies in populations of European descent. A meta-
analysis using data from six independent studies comprising 3,161
glaucoma cases and 42,837 controls found evidence for rs190004
(near ATOH7), rs1063192 (in CDKN2B and the overlapping gene
CDKN2B-AS1) and rs10483727 (near SIX1 gene) significantly
associated with POAG [24]. Wiggs and her coworkers evaluated
the association between SNPs associated with optic disc area and
VCDR in a US Caucasian case/control sample and also identified
associations between rs1063192 (in CDKN2B) and rs10483727
(near SIX1) and POAG [8]. rs1063192, The SNP related with
VCDR, appears to be the only SNP consistently associated with
POAG across the original and confirmation studies, including the
current investigation. The C allele of rs1063192, which was
reported to be significantly associated with a lower VCDR in
a genome wide association study, had a protective effect to POAG
in our Afro-Caribbean population as well as in the study by Fan
et al [8].
A recent GWAS for POAG using a discovery cohort of
590 POAG cases with severe visual field loss and 3,956 controls
also identified the POAG locus at CDKN2B/CDKN2B-AS1, with
the most highly associated SNP being rs4977757 (P=4.70610
29)
[25]. Interestingly, the antisense RNA encoded by CDKN2B-AS1
can regulate CDKN2B, with which its expression level is re-
ciprocally related [33]. Since rs1063192, the most highly
associated SNP found in this study, lies in the 39UTR of CDKN2B,
it was of interest to explore the relationship between rs1063192,
rs4977756, and POAG. However, alleles of these two SNPs are in
equilibrium in the BFSG study set (r
2=0.053), and the haplotypes
defined by these two SNPs do not show significant association with
POAG risk (data not shown). However, since the haplotype block
structure can vary significantly in different populations based on
their history, lack of association with a single SNP does not rule
out association of an entire region. Such exclusion would require
exhaustive testing of tagging SNPs throughout the area.
SNP rs1063192, associated with VCDR, is located within the
CDKN2B gene, which encodes a cyclin-dependent kinase that may
regulate cell growth and has been implicated in the transforming
growth factor beta (TGFbeta) signaling pathway. The CDKN2B
region has been associated with other diseases such as gliomas,
diabetes, and myocardial infarction [34,35,36], but the C allele of
rs1063192, which reduces the risk of glaucoma, increases the risk
for glioma. Currently the functional significance of rs1063192 is
unclear. Since this SNP resides at the 39-untranslated region
(39UTR) of CDKN2B, it is possible that the minor allele of this SNP
may alter a regulatory element that affects the expression of
CDKN2B, or it might simply be in linkage disequilibrium with
a proximate true causal variant. In this regard, rs1063192 also lies
within 10 kb of the CDKN2A promoter. Further investigation is
needed to elucidate the exact causative variant(s) underlying these
different disease associations.
Similarly, it is unclear why the C allele of rs1063192, which is
protective against glaucoma, occurs at a much lower frequency in
the Afro-Caribbean population of Barbados than in Caucasian
populations, being intermediate between sub-Sahara African (near
0) and African Americans (about 0.13). While this might represent
varying degrees of admixture, it is possible that it contributes to the
higher incidence of POAG in these populations. One possible
explanation for maintenance of these varying frequencies is that
the onset of POAG is generally after the primary reproductive
years so that it would not impact reproductive fitness greatly. In
addition, if this allele increased risk for other diseases such as
glioma [34] this could provide selective pressure to lower the allele
frequency, especially if the risk was increased in the African
relative to European populations.
SNP rs7916697, which plays a key role in controlling optic disc
area, lies within ATOH7, a basic helix-loop-helix transcription
factor required for retinal ganglion cell and optic nerve de-
velopment [37]. Although this SNP is only marginally associated
with POAG in the Barbados population, it shows significant
interaction with SNP rs1063192 in decreasing POAG risk.
Collectively, our results suggest that both common variants
influencing normal variation in VCDR and optic disc area,
affecting transcription and development, are involved in the
development of POAG. Along with the lack of association of these
SNPs with IOP, these results suggest that the associated genes
might act through their effects on the retina and particularly in
ganglion cells. This is consistent with the results recently reported
by Wiggs et al. [38], and contrasts with the NRXN1 locus, which
is highly associated with both POAG and IOP [28].
We were unable to confirm association to a number of other
previously identified loci. The region harboring CAV1 and CAV2
genes on chromosome 7q31 has been reported to be associated
with POAG in an Icelandic population (top SNP rs4236601,
P=5.0E210) [19]. This was later confirmed by another group in
a Caucasian US population in which the confirmation study found
specific haplotypes located in the CAV1/CAV2 intergenic region to
be associated with the disease [39]. However, this association was
not seen in a set of patients from Iowa [40], although the sample
size in that study was smaller than that of Wiggs et al. [39]. We did
not observe a positive association between rs4236601 and POAG
in our Afro-Caribbean cohort. Our results suggest that this region
may not be significantly related to POAG risk in populations of
African descent. Nakano et al. demonstrated significant association
of six SNPs with POAG that flanked genes on chromosomes 1
(zona pellucida glycoprotein 4; ZP4), 10 (plexin domain containing 2;
PLXDC2), and 12 (transmembrane and tetratricopeptide repeat containing 2;
TMTC2) in a Japanese population [17], but a subsequent
replication study in an Indian population did not confirm this
finding [41]. We were not able to find significant association to any
of these six SNPs (rs547984, rs540782, rs693421, rs2499601,
rs7081455 and rs7961953) with POAG in our cohort either
(Table 3). We were also unable to replicate the association between
SRBD1, ELOVL5 and TLR4 polymorphisms and POAG in our
samples. This might be due to differences in the haplotype block
structures of the various populations, to differences on the genes
contributing to POAG risk in the populations, or perhaps simply
to the relatively small size and correspondingly reduced power of
the current study. In this regard, the Afro-Caribbean population of
Barbados has a distinctive population history combining a founder
effect from West Africa dating from the seventeenth century and
limited influx of new populations since that time. Genetic
associations generally are biologically more meaningful if they
are replicated across different ethnic groups. In that regard, this
study further supports the contributions of CDKN2B and ATOH7,
or at least nearby loci, to POAG.
In summary, our study confirmed a significant association
between SNP rs1063192 at 9p21 and POAG in the Afro-
Caribbean population of Barbados and detected an interactive
effect between rs1063192 and rs7916697 with POAG. The
identification of the same susceptibility gene in both European
and African descent populations helps to support the role of
CDKN2B/CDKN2B-AS1 in the pathogenesis of POAG. Further
CDKN2B Associated with POAG in Barbados
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39278study of this gene and its related pathways will improve our
understanding of POAG pathogenesis and its genetic susceptibility
factors.
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